Anticancer potential of lactoferrin: effects, drug synergy and molecular interactions

被引:0
|
作者
D. B. León-Flores [1 ]
L. I. Siañez-Estada [1 ]
B. F. Iglesias-Figueroa [1 ]
T. S. Siqueiros-Cendón [1 ]
E. A. Espinoza-Sánchez [1 ]
A. Varela-Ramírez [2 ]
R. J. Aguilera [2 ]
Q. Rascón-Cruz [1 ]
机构
[1] Facultad de Ciencias Químicas, Universidad Autónoma de Chihuahua, Chihuahua, Chihuahua
[2] Border Biomedical Research Center, Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX
基金
美国国家卫生研究院;
关键词
Anticancer; Drug-Lf conjugate; Lactoferrin; Lf interactions; Lf receptors;
D O I
10.1007/s10534-025-00672-y
中图分类号
学科分类号
摘要
Cancer treatment is among today’s most active and challenging research fields. In recent years, significant progress has been made in developing new cancer therapies, including nutraceuticals and natural compounds with anticancer properties. Lactoferrin, a glycoprotein present in mammals, is of significant interest due to its pleiotropic behavior, demonstrating a broad spectrum of biological activities such as antimicrobial, antioxidant, anti-inflammatory, immunomodulatory, and anticancer effects. In this review, we examine the current knowledge of Lf's role in cancer. In addition, it exhibits a synergistic effect along with conventional drugs, potentially enhancing their efficacy and, at the same time, reducing the side effects associated with most traditional therapies. However, it is essential to consider the precise molecular mechanism by which Lf exerts its antitumor activity. Searching interactions with several molecules can provide insight into this mechanism. Additionally, finding lactoferrin receptors can improve the strategies for the specific release of the conjugates. For all these reasons, Lactoferrin becomes a potential therapeutic agent that should be examined in depth. © The Author(s), under exclusive licence to Springer Nature B.V. 2025.
引用
收藏
页码:465 / 484
页数:19
相关论文
共 50 条
  • [1] Empagliflozin: a potential anticancer drug
    Wenwen Wu
    Yanyan Wang
    Jun Xie
    Shaohua Fan
    Discover Oncology, 14
  • [2] Empagliflozin: a potential anticancer drug
    Wu, Wenwen
    Wang, Yanyan
    Xie, Jun
    Fan, Shaohua
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [3] Different Pathways Mediate Amphotericin-Lactoferrin Drug Synergy in Cryptococcus and Saccharomyces
    Lai, Yu-Wen
    Pang, Chi Nam Ignatius
    Campbell, Leona T.
    Chen, Sharon C. A.
    Wilkins, Marc R.
    Carter, Dee A.
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [4] Solid state and solubility study of a potential anticancer drug-drug molecular salt of diclofenac and metformin
    Feng, Wen-Quan
    Wang, Ling-Yang
    Gao, Jie
    Zhao, Ming-Yu
    Li, Yan-Tuan
    Wu, Zhi-Yong
    Yan, Cui-Wei
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1234
  • [5] Assessment of Broad-Spectrum Antimicrobial, Antibiofilm, and Anticancer Potential of Lactoferrin Extracted from Camel Milk
    Alkhulaifi, Manal M.
    Alosaimi, Malak M.
    Khan, Mohd Shahnawaz
    Tabrez, Shams
    Shaik, Gouse M.
    Alokail, Majed S.
    Hassan, Mohammed A.
    Awadalla, Muawiya E.
    Husain, Fohad Mabood
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (03) : 1464 - 1480
  • [6] Assessment of Broad-Spectrum Antimicrobial, Antibiofilm, and Anticancer Potential of Lactoferrin Extracted from Camel Milk
    Manal M. Alkhulaifi
    Malak M. Alosaimi
    Mohd Shahnawaz Khan
    Shams Tabrez
    Gouse M. Shaik
    Majed S. Alokail
    Mohammed A. Hassan
    Muawiya E. Awadalla
    Fohad Mabood Husain
    Applied Biochemistry and Biotechnology, 2024, 196 : 1464 - 1480
  • [7] Molecular targets and anticancer potential of evodiamine
    Wang, Yangyang
    Ma, Hongying
    Narula, Acharan
    Liu, Lian
    Ahn, Kwang Seok
    PHYTOCHEMISTRY LETTERS, 2022, 52 : 92 - 103
  • [8] Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy
    Zhang, Yunlei
    Lima, Cristovao F.
    Rodrigues, Ligia R.
    NUTRITION REVIEWS, 2014, 72 (12) : 763 - 773
  • [9] Tebrophen - An Old Polyphenol Drug with Anticancer Potential
    Rubelj, Ivica
    Stepanic, Visnja
    Jelic, Dubravko
    Vidacek, Nikolina Skrobot
    Kalajzic, Andrea Cukusic
    Ivankovic, Milena
    Nujic, Krunoslav
    Matijasic, Mario
    Verbanac, Donatella
    MOLECULES, 2012, 17 (07) : 7864 - 7886
  • [10] Plasmalemmal V-ATPase as a Potential Biomarker for Lactoferrin-Based Anticancer Therapy
    Santos-Pereira, Catia
    Rodrigues, Ligia R.
    Corte-Real, Manuela
    BIOMOLECULES, 2022, 12 (01)